Houlihan Lokey Advises Equistone

Houlihan Lokey is pleased to announce that its Capital Markets Group has successfully arranged a fully committed debt financing package backing the acquisition of a majority stake in Omnicare Beteiligungs GmbH (Omnicare) by Equistone Partners GmbH (Equistone). The transaction closed on 31 October 2019.

Equistone is an independent private equity firm with operations across France, Germany, Switzerland, and the UK, investing as a strategic partner alongside management teams. The sponsor invests out of its most recently closed fund, Equistone Partners Europe Fund VI, with total capital commitments of €2.8 billion.

Founded in 2002, Omnicare is a pharmaceutical wholesaler operating throughout Germany that primarily distributes finished medicinal products to compounding pharmacies for the patient-specific production of cancer drugs. The company distributes the products of pharmaceutical companies to a nationwide network of compounding pharmacies that serve oncological patients across Germany. Omnicare generates revenues of approximately €670 million and employs a staff of 193.

Houlihan Lokey served as the exclusive financing advisor to Equistone and ran an accelerated process to arrange, structure, and negotiate the financing to back the acquisition.


You are about to leave
Houlihan Lokey's website

The link below leads to a website that is not
owned by Houlihan Lokey.

Continue to the external website,
close the window to remain on HL.com